Edition:
United Kingdom

Heron Therapeutics Inc (HRTX.OQ)

HRTX.OQ on NASDAQ Stock Exchange Capital Market

17.18USD
16 Aug 2019
Change (% chg)

$0.28 (+1.66%)
Prev Close
$16.90
Open
$16.99
Day's High
$17.25
Day's Low
$16.79
Volume
218,480
Avg. Vol
344,484
52-wk High
$41.05
52-wk Low
$15.68

About

Heron Therapeutics, Inc. is a biotechnology company engaged in developing pharmaceutical products for patients suffering from cancer or pain. The Company's product candidates include SUSTOL, HTX-019 and HTX-011. All of its product candidates utilize science and technology platforms, including its Biochronomer drug delivery... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $1,399.36
Shares Outstanding(Mil.): 79.19
Dividend: --
Yield (%): --

Financials

  HRTX.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -2.47 -- --
ROI: -87.02 7.52 12.69
ROE: -89.42 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates